Long-term impact of COVID-19 associated acute respiratory distress syndrome
- PMID: 34400219
- PMCID: PMC8363182
- DOI: 10.1016/j.jinf.2021.08.018
Long-term impact of COVID-19 associated acute respiratory distress syndrome
Abstract
Objectives: To determine the health status, exercise capacity, and health related quality of life (HRQoL) of COVID-19 associated acute respiratory distress syndrome (ARDS) survivors, 8 months after diagnosis.
Methods: All eligible patients were interviewed and underwent a physical examination, chest X-ray, and 6 min walk test (6MWT). Scales to evaluate post-traumatic stress disorder, depression, anxiety, and HRQoL were applied.
Results: Of 1295 patients, 365 suffered ARDS and 166 survived to hospital discharge. Five died after discharge and 48 were lost to follow-up. Of the 113 remaining patients, 81% had persistent symptoms. More than 50% of patients completed less than 80% of the theoretical distance on the 6MWT, 50% had an abnormal X-ray and 93% of patients developed psychiatric disorders. Mean SF-36 scores were worse than in the general population. After multivariate regression analysis, female sex, non-Caucasian race, and Charlson index>2 were independent risk factors for a worse mental health component summary score on the SF-36, and age was associated with a better prognosis. Female sex and chronic obstructive pulmonary disease were independently associated with a worse physical component summary score.
Conclusion: COVID-19 associated ARDS survivors have long-term consequences in health status, exercise capacity, and HRQoL. Strategies addressed to prevent these sequelae are needed.
Keywords: ARDS; COVID-19; Long-term outcomes; SARS-CoV2; Sequelae.
Copyright © 2021. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest There are no funders to declare.
Figures
References
-
- Statement on the second meeting of the International Health Regulations (2005). Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). [Internet]. [cited 2021 May 2]. Available from: https://www.who.int/.
-
- Wiersinga W.J., Rhodes A., Cheng A.C., Peacock S.J., Prescott H.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324:782–793. - PubMed
-
- Gutiérrez-Gutiérrez B., del Toro M.D., Borobia A.M., Carcas A., Jarrín I., Yllescas M., et al. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicenter cohort study. Lancet Infect Dis. 2021;21(3099) - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous